![]() |
Volumn 13, Issue 4, 2010, Pages
|
Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration
|
Author keywords
Adult onset Still's disease; Etanercept; Macrophage activation syndrome; TNF
|
Indexed keywords
ETANERCEPT;
FERRITIN;
IMMUNOGLOBULIN;
METHYLPREDNISOLONE;
PREDNISOLONE;
TRIACYLGLYCEROL;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
ADULT ONSET STILL DISEASE;
ARTICLE;
CASE REPORT;
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
ERYTHROPHAGOCYTOSIS;
FERRITIN BLOOD LEVEL;
HUMAN;
LABORATORY TEST;
MACROPHAGE ACTIVATION SYNDROME;
MALE;
MULTIPLE CYCLE TREATMENT;
PHYSICAL EXAMINATION;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
TREATMENT RESPONSE;
TRIACYLGLYCEROL BLOOD LEVEL;
ADULT;
ANTIRHEUMATIC AGENTS;
GLUCOCORTICOIDS;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULINS, INTRAVENOUS;
INFLAMMATION MEDIATORS;
MACROPHAGE ACTIVATION SYNDROME;
MALE;
METHYLPREDNISOLONE;
PLASMA EXCHANGE;
PULSE THERAPY, DRUG;
RECEPTORS, TUMOR NECROSIS FACTOR;
STILL'S DISEASE, ADULT-ONSET;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
UP-REGULATION;
|
EID: 77958090001
PISSN: 17561841
EISSN: 1756185X
Source Type: Journal
DOI: 10.1111/j.1756-185X.2010.01544.x Document Type: Article |
Times cited : (30)
|
References (8)
|